The hypothesis of N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia was initially based on observations that blockade of the NMDA subtype of glutamate receptor by noncompetitive antagonists, such as phencyclidine and ketamine, can lead to clinical symptoms similar to those present in schizophrenia. Recently, glutamate has also been implicated in the pathophysiology of the mood disorders. As impaired NMDA receptor activity may be the result of a primary defect in the NMDA receptors themselves, or secondary to dysfunction in the protein complexes that mediate their signaling, we measured expression of both NMDA subunits and associated postsynaptic density (PSD) proteins (PSD95, neurofilament-light (NF-L), and SAP102) transcripts in the dorsolateral prefrontal cortex in subjects with schizophrenia, bipolar disorder, major depression, and a comparison group using tissue from the Stanley Foundation Neuropathology Consortium. We found decreased NR1 expression in all three illnesses, decreased NR2A in schizophrenia and major depression, and decreased NR2C in schizophrenia. We found no changes of NR2B or NR2D. Receptor autoradiography revealed no alterations in receptor binding in any of the illnesses, indicating no change in total receptor number, but taken with the subunit data suggests abnormal receptor stoichiometry. In the same subjects, PSD95 was unchanged in all three illnesses, while reduced NF-L expression was found in schizophrenia, especially in large cells of layer V. SAP102 expression was reduced in bipolar disorder restricted to small cells of layer II and large cells of layer III in bipolar disorder. These alterations likely reflect altered signaling cascades associated with glutamate-mediated neurotransmission within specific cortical circuits in these psychiatric illnesses.
INTRODUCTION
The hypothesis of N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia was initially based on observations that blockade of the NMDA subtype of glutamate receptor by noncompetitive antagonists, such as phencyclidine and ketamine, can lead to clinical symptoms similar to those present in schizophrenia (Hertzmann et al, 1990) . Subsequent studies have demonstrated that NMDA receptor antagonists can also lead to alterations in physiologic measures, including impaired prepulse inhibition (Duncan et al, 2004 Shoemaker et al, 2005; Moy et al, 2006) and increased subcortical dopamine release, which are observed in schizophrenia as well (Geyer and Braff, 1987; Grillon et al, 1992; McDowd et al, 1993; Braff et al, 1999) . Given these observations, the possibility of NMDA hypofunction in schizophrenia is an attractive and viable hypothesis. However, impaired NMDA receptor activity may be the result of a primary defect in the NMDA receptors themselves, or secondary to dysfunction in the postsynaptic proteins that mediate their signaling, leading to diminished NMDA receptor activity. Past studies on the expression of ionotropic glutamate receptors in psychiatric illnesses have focused almost exclusively on schizophrenia, and have concentrated on cortical and medial temporal lobe structures, generally revealing complex region-and receptor-specific abnormalities (McCullumsmith et al, 2004) . Although previous reports have found alterations of glutamate receptor expression in schizophrenia, it is not well established if these receptors are also abnormal in the mood disorders, even though glutamate transmission abnormalities have been suggested for major depression (MDD) and bipolar disorder (BD) (Belsham, 2001a, b; Meador-Woodruff et al, 2001b; McCullumsmith and Meador-Woodruff, 2002; Molnar et al, 2003a; Du et al, 2004; Mueller and Meador-Woodruff, 2004; Woo et al, 2004) .
NMDA glutamate receptors are combinations of six subunits, NR1, NR2A-D, and NR3, which form specific binding sites that provide substrates for the pharmacological regulation of the NMDA receptor. There is a primary binding site for glutamate, and separate polyamine and glycine (D-serine)-binding sites. Glutamate receptors and downstream signaling enzymes are targeted to a postsynaptic specialization of excitatory synapses known as the postsynaptic density (PSD). Apart from subunit composition of receptors, membrane insertion, functionality, and response to glutamate can be regulated by interactions with PSD proteins that can alter receptor sensitivity to glutamate and modulate signaling cascades by linking glutamate receptors to intracellular effector molecules. Proteins containing PDZ motifs play central roles in scaffolding NMDA receptors and linking them to signaling elements (Kennedy, 1997; Craven and Bredt, 1998; Hsueh and Sheng, 1998; Garner et al, 2000) . The prototypical PDZ protein, PSD95, is a membrane-associated guanylate kinase (MA-GUK) that contains three PDZ domains and associates with NMDA receptors. Two other MAGUKs, PSD-93 and synapse-associated protein SAP102, are also expressed in neurons throughout the brain. Some related proteins, such as neurofilament-light (NF-L), link NMDA receptors to the dendritic spine cytoskeleton.
In this study, we hypothesized that there are abnormalities of proteins associated with NMDA-mediated glutamate transmission in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia. Accordingly, we assessed the expression of the NMDA subunits and three of the proteins implicated in their trafficking and signaling (PSD95, SAP102, and NF-L) by in situ hybridization, as well as measuring receptor binding with MK801, ifenprodil, CGP39653, and MDL105519 in schizophrenia, MDD, BD, and a comparison group. We predicted that any changes in NMDA receptorrelated molecules in schizophrenia may be localized to specific cellular subpopulations in DLPFC, consistent with previous studies that found lamina-and cell-specific somatodendritic alterations in this illness that have been interpreted to suggest decreased synaptic connectivity of those cells. To determine the laminar and cellular specificity of any changes of the PSD proteins in schizophrenia and the mood disorders, cell-level in situ hybridization studies were also conducted.
MATERIALS AND METHODS

Subjects and Tissue Preparation
This study was done on post-mortem brains from 60 subjects obtained from the Stanley Foundation Neuropathology Consortium, consisting of 15 subjects each with diagnoses of schizophrenia, BD, MDD, and a comparison group (Torrey et al, 2000 ; Table 1 ). Serial sections (14 mm thick) were provided by the Stanley Foundation and stored at À801C.
In Situ Hybridization Histochemistry
Riboprobes were synthesized from linearized plasmids containing subclones of the NMDA receptor subunits (NR1, NR2A-D), and the related intracellular proteins PSD95, SAP102, and NF-L (Table 2) . Each NMDA subunit probe recognized all known isoforms and editing variants. Briefly, 10 ml of [ 35 S]-UTP was dried and 2.0 ml 5 Â transcription buffer; 1.0 ml 0.1 M dithiothreitol (DTT); 1.0 ml each of 10 mM ATP, CTP, and GTP; 2.0 ml linearized plasmid; 0.5 ml RNase inhibitor; and 1.5 ml T3, T7, or Sp6 RNA polymerase were mixed and incubated for 2 h at 371C. A total of 1.0 ml DNase (RNase-free) was then added, and the mixture was incubated for 15 min at room temperature. The reaction mixture was separated through spin columns (Micro Bio-Spin P-30 Tris Chromatography Columns, BioRad Laboratories, Richmond, CA) and the purified fraction was eluted. DTT was added to each fraction to a final concentration of 0.01 M. Two slides per subject for each probe were removed from À801C storage and placed in 4% (weight:vol) formaldehyde at room temperature for 1 h. They were then rinsed in 2 Â standard saline citrate (SSC, 300 mM sodium chloride, and 30 mM sodium citrate, pH 7.2) and subsequently treated with 0.1 M triethanolamine (pH 8.0)/acetic anhydride (400 : 1) with stirring for 10 min at room temperature. The sections were rinsed in 2 Â SSC for 5 min and dehydrated in graded alcohols before air-drying. [ 35 S]-labeled probes were applied diluting 3-5 Â 10 6 c.p.m. in 400 ml per slide of hybridization buffer (50% deionized formamide, 3 Â SSC, 1 Â Denhardt's solution (0.02% polivinylpyrrolidone, 0.02% Ficoll, 0.02% bovine serum albumin), 2% yeast tRNA (10 mg/ml), 50 mM sodium phosphate (pH 7.4), and 10% dextran sulfate in sterile water). Slides were covered with glass coverslips, and placed in humid chambers containing an atmosphere saturated with 50% formamide at 551C overnight.
After 16 h of hybridization, coverslips were removed and sections were washed three times in 2 Â SSC at room temperature, immersed in RNAse A (200 mg/ml in 10 mM Tris, 0.5 M NaCl, pH 8.0) for 30 min at 371C, and then washed through descending concentrations of SSC to a final stringency of 0.5 Â SSC at 551C for 1 h. Finally, the sections were dehydrated in graded ethanol washes, allowed to airdry, and placed in X-ray cassettes and exposed to Kodak Biomax MR film (Kodak, Rochester, NY) for 7-14 days.
For each probe, all subjects were run in the same experiment to eliminate interassay variability. Control slides were used to confirm the specificity of each riboprobe, running 'sense-strand'-labeled sections in parallel with those labeled with 'antisense-strand' probes.
Receptor Autoradiography
Receptor autoradiography was carried out under saturating conditions of ligand using assays that have been previously described in detail (Huettner and Bean, 1988; Ransom and Stec, 1988; Sills et al, 1991; Hashimoto et al, 1994; Baron et al, 1996; Siegel et al, 1996; White and Vogel, 1996; Healy et al, 1998; Healy and Meador-Woodruff, 1999; Ibrahim et al, 2000a, b 
Image Analysis
Image analysis of in situ hybridization. Developed films were digitized and quantitated using NIH Image (v1.56) on a CCD-based imaging system. Each transcript showed a distinct pattern of laminar distribution across the cortical thickness, and gray scale values were obtained from bands with densities different from adjacent lamina (isodense bands). By overlapping images from thionin counterstaining of the same slides, we were able to correlate isodense bands (1-6) to cytoarchitectural cortical layers (I-VI).
Isodense bands did not correspond exactly with traditionally defined cortical layers. Gray scale values from isodense bands were corrected for tissue background, and then converted to optical density (OD). OD values were converted to amount of radioactivity bound (nCi/g) determined from calibrated [ 14 C] microscale standards (Miller, 1991) . Using the number of uridine residues contained in each molecule, the bound radioactivity value was converted to concentration of mRNA per isodense band, expressed as fmol/g of tissue. The values from two slides per subject were then averaged to obtain a single value for concentration of each mRNA in each isodense band.
Image analysis of receptor autoradiography. Developed films were digitized and quantitated using NIH Image software. For each cortical isodense band, gray scale values from the 'total' binding slides were corrected for nonspecific binding from an adjacent slide, and gray scale value was converted to OD. The final value was averaged from two slides per subject.
Cell-Level Autoradiography
To evaluate the mRNA expression of the PSD proteins at the cellular level, we used high-resolution autoradiographic analysis and silver-grain counting. After exposure to film, we coated hybridized sections with Kodak NTB-2 nuclear emulsion diluted 1 : 1 with sterile water (Kodak). To ensure the consistency of emulsion thickness across sections, we dipped the slides using a Pelco Auto-Dip Emulsion Coater (Ted Pella Inc., Redding, CA), as previously described (Hashimoto et al, 2003) . The dipping process was at a constant withdrawal speed (64 mm/min) and temperature (431C). The sections were air-dried for 3 h at room temperature and stored in darkness at 41C. Test slides were developed at weekly intervals to determine optimal exposure time. After 4-5 weeks, all slides were developed in Kodak D19 developer for 2 min, washed in distilled water for 30 s, and fixed in Kodak Rapid Fix for 3 min. Following washing in deionized water for 10 min, the sections were counterstained with thionin, dehydrated in graded alcohols, cleared in xylene, and coverslipped in Permount.
Cellular level autoradiography image analysis. For those PSD proteins for which mRNA expression was changed at the lamina level based on film analysis, we determined if alterations were cell-type specific. Using a Microcomputer Imaging Device system and a Leica DM5000 microscope, we counted silver grains/cell from emulsion-dipped slides by sampling four non-overlapping 220 Â 220 mm frames arbitrarily selected from each cortical layer. Cells were identified by counterstaining each section with thionin. As treatment with RNase during in situ hybridization destroys Nissl bodies, it was difficult to draw the contours of the somata of cells, thus we counted grains from each subject by encircling nuclei of 150-200 labeled cortical cells per lamina of four different diameters, depending on the cortical layer where they were located: large cells of layers II, IV, and VI (18 mm), large cells of layer III (22 mm), large cells of layer V (26 mm), and small cells in all layers (14 mm) (Figure 1 ). These diameters correspond to those previously described in the human prefrontal cortex (Benes et al, 1996) . The larger cells include pyramidal neurons in layers II-VI, as well as basket cells (in layers III-VI) and spiny stellate cells (in layer IV), while the smaller cells are a mixture of a number of cell types (bipolar, double bouquet, neurogliaform, Martinotti, and chandelier cells). Most of those smaller cells are GABAergic, except for bipolar cells that are glutamatergic. In the corresponding dark-field image, the software determined the number of silver grains in each circle. The precision of the obtained measurements was given by the software; for all cases we established the threshold of light intensity and size to be considered as positive labeling (silver grains vs dust/artifact), considering positive labeling any number of silver grains above three per cell after subtracting the background. We determined the background value for grain expression for each section by placing circles of the same diameters used for each lamina over underlying white matter, and subtracted that value to get a corrected grains/cell count from each cell. We averaged the corrected number of grains/cell from each circle diameter in each cortical layer from two slides per subject, resulting in two values per cortical layer per subject, one corresponding to large cells (18, 22, or 26 mm) and the other to small cells (14 mm).
Statistical Analysis
The dependent variables in the in situ hybridization studies were mRNA concentration for each receptor subunit or PSD protein in each cortical isodense band, for receptor autoradiography was binding in each isodense band, and for cell-level transcript studies was grains/cell. 
RESULTS
NMDA Receptor Subunits
In situ hybridization. NMDA subunit mRNA expression was highest for NR1, followed by NR2A and NR2B; NR2C and NR2D were considerably rarer. All NMDA subunits were expressed in a similar laminar pattern, with three isodense bands of relatively higher intensity corresponding to layers II, IV, and VI (Figure 2) . In situ hybridization experiments revealed an association between pH and the NR1 subunit (r ¼ 0.41, p ¼ 0.0009) and ANCOVA with pH as covariate revealed a main effect for diagnosis (F ¼ 3.7, d.f. ¼ 3335, p ¼ 0.01) (Figure 2a) . Post hoc analysis showed a significant decrease of NR1 in schizophrenia (po0.0001), MDD (p ¼ 0.004), and BD (p ¼ 0.009) (Figure 2f ). NR2A was correlated with pH as well (r ¼ 0.46, po0.001), and ANCOVA revealed a main effect for diagnosis (F ¼ 3.03, d.f. ¼ 3335, p ¼ 0.03) (Figure 2b) ; post hoc tests revealed decreased expression of NR2A in schizophrenia (po0.0001) and MDD (p ¼ 0.0002) (Figure 2f ). Regression analysis for NR2B subunit showed significant association with age (r ¼ 0.3, p ¼ 0.02). ANCOVA indicated a main effect of diagnosis for this subunit (F ¼ 3.83, d.f. ¼ 3335, p ¼ 0.01) that post hoc tests revealed as due to difference between groups (BD vs schizophrenia, p ¼ 0.04) and not compared to control (Figure 2c and f) . No associations were found between NR2C expression and pH, PMI or age, and ANOVA revealed a main effect of diagnosis (F ¼ 8.65, d.f. ¼ 3336, po0.0001) that post hoc testing indicated was due to decreased expression in schizophrenia (po0.0001) (Figure 2d and f) . Regression analysis for NR2D showed no correlation of the expression of this subunit with age, PMI, or pH. ANOVA indicated a main effect for diagnosis (F ¼ 2.66, d.f. ¼ 3336, p ¼ 0.05) but post hoc analysis did not reveal any significant difference between groups (Figure 2e and f) . We did not Figure 2 Representative in situ hybridization images of transcripts encoding the NMDA receptor subunits in the DLPFC (a-e). The cortical layers for each image are marked in left margin. In the right margin, graphs represent mRNA concentration (fmol/g) in each isodense band for the four subject groups. (f) (Figure 3) . Receptor autoradiography revealed less complex isodense banding patterns than seen from in situ hybridization studies of subunit transcripts, with binding sites labeled by NMDA radioligands more homogeneously expressed through cortical layers (Figure 3) . (Figure 3c ). We found no differences by diagnosis in the binding of any of the NMDA ligands (Figure 3 ).
NMDA Receptor Interacting Proteins
The NMDA-related PSD proteins PSD95, SAP102, and NF-L were highly expressed throughout the DLPFC (Figure 4) . Although expressed across all cortical laminae, all three showed the highest level of expression in layers III and V. Grain-counting analyses indicated that all three transcripts are expressed in both large and small cells (Figure 1) , likely pyramidal cells and interneurons, respectively. Some glial cells appeared to express all three transcripts as well (Figure 1) .
Multiple regression analysis of PSD95 expression revealed an association with both PMI (r ¼ 0.32, p ¼ 0.02) and pH (r ¼ 0.41, p ¼ 0.002). ANCOVA with both parameters as covariates showed no main effect of diagnosis for expression of PSD95 transcripts. Cell-level grain-counting experiments confirmed the lack of any changes in PSD95 expression (Figure 4a) .
There was an association between the expression of NF-L and pH (r ¼ 0.35; p ¼ 0.01) but not age or PMI. ANCOVA showed a main effect for diagnosis (F ¼ 5.35, d.f. ¼ 3244, p ¼ 0.001), and post hoc analysis revealed decreased expression in schizophrenia (po0.0001) (Figure 4b ). Regression analysis for grains/cell data confirmed the decreased expression of this molecule in schizophrenia compared to controls (F ¼ 9.03, d.f. ¼ 1130, p ¼ 0.003), and was restricted to large cells of layer V (p ¼ 0.007) ( Figures  1b, 5a and b) .
Regression analysis of SAP102 expression showed no associations with pH, PMI, or age. ANOVA for SAP102 revealed a main effect for diagnosis (F We carried out correlation analysis of the expression of the NMDA subunits and their related postsynaptic proteins, often finding positive correlations as for NR1 and NR2A (po0.0001) and NR2B (po0.05), and for NR1 and NF-L (po0.0001) in schizophrenia, as expected by the known interaction pattern of the proteins comprising the NMDA receptor complex.
DISCUSSION
We found significant changes in the expression of NMDA receptor subunit transcripts in schizophrenia and mood disorders in DLPFC. Some previous publications found no changes in NMDA receptor expression in these illnesses (Kornhuber et al, 1989; Akbarian et al, 1996b) . However, our results are consistent with other reports that have identified significant changes in ionotropic receptors in schizophrenia (Meador-Woodruff et al, 2001a) . A shift in the relative proportion of transcripts encoding the NR2 subunits was found in schizophrenia by Akbarian et al (1996a) , a finding that correlates with our in situ hybridization results. Using reverse transcriptase polymerase chain reaction (RT-PCR), decreased NR1 mRNA in frontal cortex was found (Sokolov, 1998) , while Dracheva et al (2001) found increased expression of NR1 and NR2A but not NR2B transcripts in DLPFC and occipital cortex by RT-PCR. The lack of correspondence between some of our results in schizophrenia and several previous reports of ionotropic receptor expression abnormalities in DLPFC may be due to several factors that could affect mRNA expression. Differences between experimental techniques and subjects characteristics (eg hospitalization status, medication exposure, and age of patients at the time of death) are key factors that may be associated with discrepancies between post-mortem studies.
The abnormal expression of NMDA subunits, together with the lack of changes in receptor binding, suggests a possible change in the stoichiometry of the receptor, which might affect its pharmacology and response to glutamate, as well as its insertion in the postsynaptic membrane. It is interesting that the most robust changes in DLPFC in the three illnesses included in this study involve the 'obligatory' subunit for normal NMDA receptor function, NR1. There is a multitude of cellular mechanisms that regulate the assembly of NMDA receptor subunits into functional channels, endoplasmic reticulum (ER) retention or release, and intracellular trafficking and eventual synaptic delivery (McIlhinney et al, 1998 (McIlhinney et al, , 2003 Standley et al, 2000; Meddows et al, 2001; Roche et al, 2001; Sans et al, 2001 Sans et al, , 2003 Malinow, 2002, 2005; Wenthold et al, 2003a, b) . Demonstration of these effects is found in interesting results from a selective knockout of the NR1 gene, which demonstrated that disrupting NMDA receptor subunit composition impairs normal subcellular targeting of NMDA channels (Fukaya et al, 2003) . NR1 deletion in the CA1 hippocampal region leads to retention of the NR2B subunit in the lumen of the ER and accumulation of this subunit in the perikarya. This alteration in ER transit results in reduced expression of the NR2B subunit in NMDA receptors in dendrites (Fukaya et al, 2003) .
Alterations of glutamate subunit expression not only can change the electrophysiology of the receptors themselves, but can also change the probability of coupling the receptor to intracellular proteins that mediate many intracellular processes. Pharmacological and post-mortem studies suggest that alterations of glutamatergic neurotransmission occur in schizophrenia and the mood disorders. While this is often assumed to be due to changes in glutamate receptor expression, these alterations might also be a consequence of abnormal protein interactions that could result in misplacement of glutamate receptors in different cellular compartments, lack of stabilization of the receptors in the PSD, abnormal binding to intracellular effector molecules, or dysregulation of receptor turnover. These processes are mediated by, among others, the PSD proteins in the present study. In the right margin, graphs represent mRNA concentration (fmol/g) in each isodense band for the four subject groups. *Significant differences from the comparison group (po0.05). SAP102 was decreased in bipolar subjects, and neurofilament-light (NF-L) in schizophrenia. Scale bar: 1 mm.
Abnormalities of NMDA-Associated Proteins in Schizophrenia and Mood Disorders
NMDA receptors are anchored in the postsynaptic membrane and linked to a large complex of intracellular proteins, including PSD95, SAP102, and NF-L. While PSD95 and SAP102 bind exclusively to NR2 subunits, NF-L binds to NR1. In our experiments, we found no changes in PSD95 expression, but decreased transcripts encoding NF-L in schizophrenia and SAP102 in BD. Previous studies have examined PSD95 expression in schizophrenia, and although a previous study found decreased transcript expression in DLPFC (Ohnuma et al, 2000) , our results coincide with those that found no changes in PSD95 expression in the cerebral cortex by RT-PCR (Dracheva et al, 2005) , immunoautoradiography (Toro and Deakin, 2005) , and western blot analysis (Toyooka et al, 2002) . Toyooka et al (2002) found decreased SAP102 protein expression in the hippocampus but not DLPFC in schizophrenia. Abnormal SAP102 expression in BD could affect the regulation of NMDA receptor exocytosis in the PSD, as SAP102 is a key protein in the exocyst complex that transports NMDA receptors from the ER to the postsynaptic membrane (Sans et al, 2003) .
Previous reports suggest that the intracellular machinery that is coupled to the NMDA receptor subunits is abnormal in BD in the hippocampus (McCullumsmith et al, 2007) and in the thalamus . Consistent with our results, both studies found decreased expression of transcripts for SAP102 in BD. These data support our results, suggesting that BD might be associated with abnormalities of glutamate-linked intracellular signaling and trafficking processes.
While PSD95 and SAP102 bind to NR2 subunits, NF-L binds to NR1 and maintains the stability of the NMDA receptor in the PSD by binding actin filaments of the cytoskeleton of the dendritic spine (Ehlers et al, 1995 (Ehlers et al, , 1998 . This characteristic suggests that decreased NF-L expression in schizophrenia might be part of a more generalized cytoskeletal disruption in the cell as a response to the illness, or alternatively be associated with the decreased expression of this subunit in the same subjects. This suggests a possible instability of NMDA receptors in the postsynaptic membrane that may affect recycling and turnover at the spine, perhaps altering the number of receptors available at the membrane or their clustering at the synapse. Apart from trafficking and stabilizing NMDA receptors at the PSD, NF-L also interacts with protein phosphatase-1 (PP1), an important protein/serine/threonine phosphatase that modulates numerous intracellular pathways (Shenolikar, 1995; Terry-Lorenzo et al, 2000) . It has been proposed that NF-L might bind PP1 and position it 
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M Beneyto and JH Meador-Woodruff to dephosphorylate other proteins such as CaMKII, actin, or NMDA receptors (Shenolikar, 1995; Terry-Lorenzo et al, 2000) , mechanisms that could also be affected by the reduction of NF-L expression we found in schizophrenia. Future examination of posttranslational processes will need to be performed to confirm this hypothesis.
Cellular and Laminar Abnormalities in PSD Proteins Expression
Our data from cell-level mRNA expression analysis reveal that alterations in NF-L expression in DLPFC in schizophrenia are exclusively located in the large cells of cortical layer V. Histograms of labeled vs nonlabeled cells showed no subpopulation of cells expressing PSD proteins of each cell size (large vs small cells) (data not shown), patterns shown for some other proteins in the prefrontal cortex (Hashimoto et al, 2005) and striatum (Gerfen et al, 1991) . This suggests that the vast majority of cells in which we saw differences in PSD protein expression are pyramidal cells of layers III and V. Thalamocortical input to the pyramidal cells of the DLPFC almost exclusively innervate layer IV, but those terminals have been shown to make synaptic contact with the apical dendrites of the pyramidal cells of layer V (Staiger et al, 2004) . Interestingly, layer V receive also modest projections from the spiny stellate cells of layer IV, where most thalamocortical afferents are located. Recent studies have shown that layer-IV spiny neurons form a highly interconnected local excitatory network that is able to amplify weak thalamic input before it is relayed to the supragranular layers (Stratford et al, 1996; Feldmeyer et al, 1999 Feldmeyer et al, , 2002 . Our results suggest a dysregulation of the expression of the molecules implicated in glutamatergic signaling in layer V in schizophrenia. This may produce abnormal reception of thalamocortical and layer-III and -IV synapses, affecting afferent cortical and subcortical circuits. In BD we detected decreased expression of SAP102, exclusively in small cells of layer II and large cells of layer III of the DLPFC. Abnormal neurotransmission in projecting layer-III cells would have an effect on their ipsi-and contralateral projections to layers II and III, and locally to the apical dendrites of the pyramidal cells of layer V, while dysfunction of small layer-II cells, probably interneurons, would result in abnormalities in signal transmission modulation of inputs from layer III to layer II pyramidal cells and their subsequent corticocortical connections to other areas.
Our finding of expression of NMDA receptor-related intracellular proteins in glial cells require special mention. Aside from their important role in removing glutamate from the extracellular medium, astrocytes have been shown to respond to glutamate via activation of specific receptors. Using pharmacological and molecular approaches, astroglial expression of AMPA and kainate receptors is established (Burnashev et al, 1992; Condorelli et al, 1993 Condorelli et al, , 1999 Jabs et al, 1994; Seifert and Steinhauser, 1995; Seifert et al, 1997; Verkhratsky and Steinhauser, 2000; Burnashev, 2005) and functional NMDA receptor expression in astrocytes has been demonstrated recently. Analysis of the functional expression of NMDA receptors in astrocytes revealed significant differences from neuronal NMDA receptors (Schipke et al, 2001 ). Subunits of NMDA receptors have been detected in astrocytes by immunohistochemistry, in situ hybridization, and PCR (Schipke et al, 2001) . Several functional studies have demonstrated NMDA-mediated currents and NMDA-induced [Ca 2 + ] responses in astrocytes (Shao and McCarthy, 1997; Ziak et al, 1998; Kondoh et al, 2001; Schipke et al, 2001) . Recordings from astrocytes in slices revealed slow currents (Schipke et al, 2001 ), which did not resemble classic NMDA receptor-mediated responses (Lalo et al, 2006; Verkhratsky and Kirchhoff, 2007) . In a very elegant study, Lalo et al (2006) identified NMDA-induced currents in cortical astrocytes, and showed that these currents can also be activated by glutamate released after stimulation of neuronal synaptic terminals as well as during spontaneous release of neurotransmitter. Our results showing expression of NMDA receptor-associated intracellular proteins further support the existence of functional NMDA receptors in cortical astrocytes.
LIMITATIONS OF THE STUDY
The direct study of the post-mortem human brain is critical in the study of psychiatric disorders, but also has important limitations. For example, markers of the quality of mRNA need to be considered. In our case, we often found significant correlations between PMI, brain pH, or age of the subjects, and the expression of the molecules studied. It has been shown that the impact of PMI on mRNA integrity in post-mortem studies is secondary to agonal status and freezing of the tissue (Harrison et al, 1995 (Harrison et al, , 1991 Kingsbury et al, 1995; Yates et al, 1990) . In this study, PMI was correlated with the expression of several of the molecules studied, and in those cases we used PMI as a covariate in the data analysis.
Although enzyme-activity measures can be affected by brain pH (Yates et al, 1990; Taylor et al, 1986; Perry et al, 1982) , immunoreactivity of brain proteins and ligand binding to receptors do not appear to vary substantially as a function of brain pH (Harrison et al, 1995) . However, tissue levels of many mRNAs can be related to brain pH (Harrison et al, 1995; Kingsbury et al, 1995) . Based on observations that sudden deaths are associated with brain pH of B6.8 and prolonged agonal states may produce a brain pH of o6.0, Harrison and Kleinman (2000) have recommended that all brains be screened for pH and those with values o6.1 be excluded from study, a recommendation that we followed in this study.
Age has been shown to be an important factor in glutamate receptor binding and mRNA expression in rodents (Magnusson, 1998 (Magnusson, , 2000 Nicolle and Baxter, 2003) . We found no significant correlations with age and NMDA binding of any of the ligands we used in this study, and except for NR2B, no associations with NMDA subunit expression and age.
In conclusion, our data suggest that both schizophrenia and BD are characterized by alterations in the transcript expression of subunits of the NMDA receptor, as well as associated intracellular proteins in the DLPFC in both illnesses. The identification of the abnormal expression of these molecules related to glutamate receptor trafficking and signaling provides evidence for the involvement of the glutamate system in the pathophysiology of schizophrenia and mood disorders.
